— Know what they know.
Not Investment Advice

MTSR NASDAQ

Metsera, Inc.
1W: -15.2% 1M: +33.4% 3M: +117.7%
$70.50
Last traded 2025-11-14 — delisted
NASDAQ · Healthcare · Biotechnology · $7.4B mcap · 48M float · 7.27% daily turnover · Short 29% of daily vol

Cash Flow Trends

Operating Cash Flow
-$100M -182.7% ▼
Capital Expenditures
$43K -48.3% ▼
Free Cash Flow
-$100M -182.5% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$277M +360.4% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2023FY2024
— Operating Activities —
Net Income-$47M-$209M
Depreciation & Amort.$2K$14K
Stock-Based Comp.$85K$0
Change in Working Capital$4M$26M
Other Non-Cash Items$8M$93M
Operating Cash Flow-$35M-$100M
— Investing Activities —
Capital Expenditures-$29K-$43K
Acquisitions (Net)-$28M$0
Investment Purchases$0$0
Investment Sales$0$0
Other Investing$0$0
Investing Cash Flow-$28M-$43K
— Financing Activities —
Net Debt Issuance$0-$252K
Stock Repurchased$0$0
Dividends Paid$0$0
Other Financing-$217K-$19M
Financing Cash Flow$124M$378M
Net Change in Cash$60M$277M
Cash End of Period$75M$352M
Free Cash Flow-$35M-$100M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms